Stock 603658 AUTOBIO DIAGNOSTICS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

All News Autobio Diagnostics Co., Ltd.

Equities

603658

CNE100002GC4

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-04-28 pm EDT 		5-day change 1st Jan Change
57.54 CNY +2.11% Intraday chart for Autobio Diagnostics Co., Ltd. +3.53% +0.93%
Apr. 19 Autobio Diagnostics' Q1 Profit Jumps 34% MT
Apr. 19 Autobio Diagnostics' 2023 Profit Climbs 4% as Operating Income Stays Flat MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Autobio Diagnostics' Q1 Profit Jumps 34%
MT
Autobio Diagnostics' 2023 Profit Climbs 4% as Operating Income Stays Flat
MT
Autobio Diagnostics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Tranche Update on Autobio Diagnostics Co., Ltd.'s Equity Buyback Plan announced on February 21, 2024.
CI
Autobio Diagnostics Secures Registration Certificates for 11 Devices
MT
Autobio Diagnostics Gets Regulatory Nod in China for 16 Devices
MT
Autobio Diagnostics Co., Ltd. commences an Equity Buyback Plan for CNY 500 million worth of its shares, under the authorization approved on February 20, 2024.
CI
Autobio Diagnostics Co., Ltd. authorizes a Buyback Plan.
CI
Autobio Diagnostics Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Autobio Diagnostics Co., Ltd.(XSSC:603658) added to S&P Global BMI Index
CI
Autobio Diagnostics Logs Low Single-Digit Earnings Growth in H1
MT
Autobio Diagnostics Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Autobio Diagnostics Gets Registration Certificates for Five Devices
MT
Shenzhen Meili Namikong Technology Co., Ltd. announced that it has received funding from Autobio Diagnostics Co., Ltd.
CI
Autobio Diagnostics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Autobio Diagnostics Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Autobio Diagnostics Co., Ltd.(XSSC:603658) added to FTSE All-World Index
CI
Tranche Update on Autobio Diagnostics Co., Ltd.'s Equity Buyback Plan announced on March 19, 2022.
CI
Autobio Diagnostics Co., Ltd.'s Equity Buyback announced on March 19, 2022, has closed with 5,260,910 shares, representing 0.90% for CNY 243.27 million.
CI
Tranche Update on Autobio Diagnostics Co., Ltd.'s Equity Buyback Plan announced on March 19, 2022.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 603658 Stock
  4. News Autobio Diagnostics Co., Ltd.